Back to Results
First PageMeta Content
Alcohols / Ketones / Euphoriants / Phenols / Buprenorphine / Opioid dependence / Methadone / Naltrexone / Naloxone / Chemistry / Organic chemistry / Morphinans


Opiate Dependence Treatments
Add to Reading List

Document Date: 2014-11-05 17:48:08


Open Document

File Size: 339,85 KB

Share Result on Facebook

City

Cincinnati / /

Company

Alkermes / Administrator Intellectual Property Department Provider Synergies L.L.C. / Provider Synergies L.L.C. / Reckitt Benckiser / Magellan Medicaid Administration Inc. / /

/

Event

Product Issues / Product Recall / FDA Phase / /

IndustryTerm

short-acting opioid products / machinery / prevention of undue symptoms / buprenorphine ethanolic sublingual solution / buprenorphine-containing transmucosal products / treatment of patients with substance abuse disorders / combination product / long-acting opioid products / /

MedicalCondition

glossodynia / oral mucosal erythema / oral hypoesthesia / *abdominal pain / liver failure / cytolytic hepatitis / coma / fatal respiratory depression / Headache Abdominal Pain Withdrawal Syndrome Constipation Nausea Insomnia / hyperhidrosis / sleeplessness / withdrawal syndrome / concomitant diseases / substance abuse disorders / opiate dependence / hypersensitivity / marked and intense withdrawal symptoms / hepatitis / constipation / liver disease / alcoholism / opiate withdrawal symptoms / head injury / hypertension / chronic obstructive pulmonary disease / naloxone hypersensitivity / acute hepatitis / active liver disease / sexual dysfunction / increased CNS depression / chronic administration / hepatic injury / orthostatic hypotension / toothache / dose causing hepatic injury / Significant respiratory depression / respiratory depression / cough / inflammation / hepatocellular injury / cor pulmonale / precipitating withdrawal syndrome / /

MedicalTreatment

dialysis / /

Movie

Half-Life / /

Organization

Pharmacy and Therapeutics committee / American Psychiatric Association / FDA / Medicaid Agency / U.S. Substance Abuse and Mental Health Services Administration / Drug Enforcement Administration / /

Position

Secretary of Health / physician / /

Product

efavirenz / symptoms / SL tablet / DOSAGES38 / 39 / 40 / 41 / 42 / 43 Drug Dosing Availability buprenorphine SL tablets / carbamazepine / Subutex / mg / Revia / Suboxone SL / Headache Abdominal Pain / Drug Dosing buprenorphine/naloxone SL / SL tablets / naloxone / phenytoin / Suboxone / opioid / opiate / disulfiram / Vivitrol / initiate / naltrexone hydrochloride / CYP drug / Zubsolv / INDICATIONS Drug / /

ProvinceOrState

Ohio / /

Technology

alpha / Geriatrics / PHARMACOKINETICS / dialysis / /

SocialTag